News

Genetic variants in the granulin gene are a risk factor for Dementia, Alzheimer's and Parkinson's, suggesting this discovery may have therapeutic potential for a broad spectrum of age-related neurodegenerative diseases.

The new paper-based diagnostic device detects biomarkers and identifies diseases by performing electrochemical analyses, and the assays change color to indicate specific test results.

By analyzing the saliva of a pregnant mother infected with Zika and her twins, researchers were able to pinpoint the specific protein signature for Zika that is present in saliva, creating potential to use this signature as an effective way to screen for exposure.

Study shows that stem cells take up an unusually high level of vitamin C, which then regulates their function and suppresses the development of leukemia.

Scientists report that avocado seed husks, which are usually discarded along with the seed, are hidden gold mines packed with a previously unrecognized plethora of chemical compounds.

Lyme disease is commonly confused with similar conditions such as STARI. A new mass spec based test can identify biomarkers of metabolic differences in the two diseases.

Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.

A recent Nature Medicine paper outlines the role of mutations within the SPOP gene on the development of resistance to one class of drugs.

ACD/Labs technology enables automatic prediction of 1H and 13C spectra, using their industry-leading NMR prediction tools, for compounds already in the database and for new compounds as they are added in future.

The chip works well even when protein biomarkers are present in extremely small numbers, as is the situation during the early stages of a disease.